Peter Marks, M.D., Ph.D., the former head of the FDA’s Center for Biologics Evaluation and Research (CBER), has joined Eli Lilly as senior vice president of molecule discovery and head of infectious ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Peter Marks, the ...

Brown dwarfs: too small to be stars, too big to be planets. Only discovered in the 1990s, these in-between cosmic objects aren’t big enough to burn as hot and bright as a true star, instead usually ...

Depression and anxiety disorders are among the most widespread mental health disorders, with estimates suggesting that they affect around 264 million and 284 million people worldwide, respectively.

NAD – a molecule lauded as a breakthrough in longevity, mental clarity and even disease prevention is de rigueur for the wellness crowd. It seems that if you’re not taking NAD, you can’t seriously ...

In this phase 3, multinational, randomized, double-blind trial, we examined the safety and efficacy of once-daily orforglipron at doses of 6 mg, 12 mg, or 36 mg, as compared with placebo (assigned in ...

In Greek mythology it was Charon, the grim ferryman, who paddled souls across the rivers Styx and Acheron to the underworld. But the real-life ferryman transporting our human souls between the realms ...

Chemists have synthesized a "super alcohol" previously thought to be too unstable to exist. The molecule was formed under extreme, "space-like" conditions and may shed light on the complex reactions ...

With the walls quickly closing in, Kronos Bio has accepted a buyout from notorious biotech acquirer Concentra Biosciences. Tang Capital Partners’ Concentra inked a definitive deal to acquire Kronos’ ...

Section 1. Purpose. My first term included numerous significant actions, including some of the most aggressive in recent history, to deliver lower prescription drug prices to American patients. The ...